annual total liabilities:
$15.91M-$10.05M(-38.70%)Summary
- As of today (August 22, 2025), ELVN annual total liabilities is $15.91 million, with the most recent change of -$10.05 million (-38.70%) on December 31, 2024.
- During the last 3 years, ELVN annual total liabilities has risen by +$9.45 million (+146.10%).
- ELVN annual total liabilities is now -38.70% below its all-time high of $25.96 million, reached on December 31, 2023.
Performance
ELVN Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$15.41M+$1.14M(+7.99%)Summary
- As of today (August 22, 2025), ELVN quarterly total liabilities is $15.41 million, with the most recent change of +$1.14 million (+7.99%) on June 30, 2025.
- Over the past year, ELVN quarterly total liabilities has dropped by -$6.70 million (-30.28%).
- ELVN quarterly total liabilities is now -40.62% below its all-time high of $25.96 million, reached on December 31, 2023.
Performance
ELVN quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
ELVN Total liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -38.7% | -30.3% |
| 3 y3 years | +146.1% | +366.8% |
| 5 y5 years | +263.2% | +207.0% |
ELVN Total liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -38.7% | +769.7% | -40.6% | +747.9% |
| 5 y | 5-year | -38.7% | +769.7% | -40.6% | +747.9% |
| alltime | all time | -38.7% | +971.0% | -40.6% | +747.9% |
ELVN Total liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $15.41M(+8.0%) |
| Mar 2025 | - | $14.27M(-10.3%) |
| Dec 2024 | $15.91M(-38.7%) | $15.91M(-6.5%) |
| Sep 2024 | - | $17.03M(-23.0%) |
| Jun 2024 | - | $22.11M(-11.8%) |
| Mar 2024 | - | $25.07M(-3.5%) |
| Dec 2023 | $25.96M(+1318.6%) | $25.96M(+111.2%) |
| Sep 2023 | - | $12.29M(+29.3%) |
| Jun 2023 | - | $9.51M(-17.0%) |
| Mar 2023 | - | $11.45M(+525.7%) |
| Dec 2022 | $1.83M | $1.83M(+0.7%) |
| Sep 2022 | - | $1.82M(-44.9%) |
| Jun 2022 | - | $3.30M(-64.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $9.19M(+20.7%) |
| Dec 2021 | $6.47M(+0.9%) | - |
| Dec 2021 | - | $7.62M(-0.5%) |
| Sep 2021 | - | $7.65M(+2.0%) |
| Jun 2021 | - | $7.50M(+23.1%) |
| Mar 2021 | - | $6.09M(-4.9%) |
| Dec 2020 | $6.41M(+46.2%) | $6.41M(+17.0%) |
| Sep 2020 | - | $5.48M(+9.1%) |
| Jun 2020 | - | $5.02M(-2.1%) |
| Mar 2020 | - | $5.13M |
| Dec 2019 | $4.38M(+139.2%) | - |
| Dec 2018 | $1.83M(+23.3%) | - |
| Dec 2017 | $1.49M | - |
FAQ
- What is Enliven Therapeutics, Inc. annual total liabilities?
- What is the all time high annual total liabilities for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. annual total liabilities year-on-year change?
- What is Enliven Therapeutics, Inc. quarterly total liabilities?
- What is the all time high quarterly total liabilities for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. quarterly total liabilities year-on-year change?
What is Enliven Therapeutics, Inc. annual total liabilities?
The current annual total liabilities of ELVN is $15.91M
What is the all time high annual total liabilities for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high annual total liabilities is $25.96M
What is Enliven Therapeutics, Inc. annual total liabilities year-on-year change?
Over the past year, ELVN annual total liabilities has changed by -$10.05M (-38.70%)
What is Enliven Therapeutics, Inc. quarterly total liabilities?
The current quarterly total liabilities of ELVN is $15.41M
What is the all time high quarterly total liabilities for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high quarterly total liabilities is $25.96M
What is Enliven Therapeutics, Inc. quarterly total liabilities year-on-year change?
Over the past year, ELVN quarterly total liabilities has changed by -$6.70M (-30.28%)